Sai Life Sciences has released its unaudited standalone financial results for the quarter and six months ended September 30, 2025. The company reported revenue from operations of ₹5,266.69 million for the quarter. Profit before tax stood at ₹1,108.71 million. Earnings per share were reported at ₹3.97 (basic) and ₹3.89 (diluted) for the quarter.
Financial Performance Overview
Sai Life Sciences announced its financial results for Q2 2026, with key highlights including:
- Revenue from operations: ₹5,266.69 million for the quarter.
- Total income: ₹5,416.02 million.
- Profit before tax: ₹1,108.71 million.
- Tax expense: ₹279.22 million.
- Profit for the period: ₹829.49 million.
Six Months Performance
The cumulative performance for the six months ended September 30, 2025, shows:
- Total income: ₹10,346.46 million.
- Profit before tax: ₹1,888.53 million.
- Earnings per share: ₹6.77 (basic) and ₹6.64 (diluted).
Balance Sheet Highlights
Key balance sheet figures include:
- Total Assets: ₹33,011.84 million.
- Equity: ₹23,032.90 million.
Auditor Review
The financial results have been reviewed by Deloitte Haskins & Sells LLP, Chartered Accountants, who issued an unmodified conclusion.
Source: BSE
